Tenovus Cancer Choirs Study: the Benefits of Singing for Those Affected by Cancer
Tenovus Cancer Choirs: the Effect of Choir Singing on Psychological and Immune Responses of Cancer Patients, Staff and Carers
1 other identifier
interventional
420
1 country
1
Brief Summary
'Sing With Us' choirs are an initiative established in Wales by Tenovus Cancer Care to provide social support and improve mental wellbeing amongst those affected by cancer, whether patients, carers or staff. Research has already demonstrated that these choirs can reduce depression and anxiety amongst participants and improve social support networks and quality of life as well as preliminary evidence that they can reduce levels of stress hormones and improve immune function. The aim of this study is to establish more about the psychological benefits of regular choir singing and explore whether the biological changes noted in pilot studies can be sustained over time. This could identify whether choirs have the potential to optimise health in people affected by cancer, helping to put patients in the best position to receive treatment or maintain remission and supporting those who care for someone with cancer, whether professionally or informally.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable cancer
Started Apr 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2016
CompletedFirst Submitted
Initial submission to the registry
April 28, 2016
CompletedFirst Posted
Study publicly available on registry
April 29, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2018
CompletedApril 29, 2016
April 1, 2016
1.7 years
April 28, 2016
April 28, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Anxiety & Depression
Hospital Anxiety and Depression Scale (HADS)
Change in anxiety and depression level at weeks 6, 12 and 24 compared to baseline
Secondary Outcomes (7)
Social Support
Change in social provision level at weeks 6, 12 and 24 compared to baseline
Wellbeing
Change in wellbeing level at weeks 6, 12 and 24 compared to baseline
Self-efficacy
Change in self-efficacy level at weeks 6, 12 and 24 compared to baseline
Self-esteem
Change in self-esteem level at weeks 6, 12 and 24 compared to baseline
General Health
Change in general health level at weeks 6, 12 and 24 compared to baseline
- +2 more secondary outcomes
Study Arms (2)
Tenovus Cancer Choir
EXPERIMENTALParticipants will be asked to attend 12 weeks of weekly choir rehearsals lasting approximately 1 hour. Following the first 12 weeks, participants will no longer be asked to attend rehearsals, but are welcome to do so. Whether or not they do and how many they attend will be measured as an outcome variable to assess whether initial 3-month involvement leads to long-term engagement.
Control (no choir) Group
NO INTERVENTIONIf eligible participants are unable to make the dates and times or live too far away but fulfil all the same criteria (including expressing an interest in singing) they will become part of the control group. This will involve the same data collection as the Cancer Choir Group but participants will not sing in a weekly choir.
Interventions
Choir sessions will take place at both of the Royal Marsden Hospital sites on a weekly basis. Sessions typically consist of learning popular songs with messages of support. Songs are learnt without sheet music, using specially created backing tracks. These are also made available to participants at home so they can continue singing away from the sessions. No singing experience is required and the main aim of the sessions is enjoyment and meeting other people. Sessions will take place in the early evening so that participants have the option of staying to socialise afterwards.
Eligibility Criteria
You may qualify if:
- COHORT A: (i) Patients with stage I-III breast cancer up to 24 months post diagnosis
- (ii) Patients with diagnosed prostate cancer on active surveillance
- (iii) Patients with colorectal cancer stages I-III up to 24 months post diagnosis
- COHORT B: (i) Members of staff at a hospital
- (ii) People who care for somebody with cancer, whether formally or informally
- (iii) People who have lost a family member or somebody they cared for to cancer in the last 3 years
- COHORT C: anybody who is affected by cancer and has joined the choir
You may not qualify if:
- Participants aged under the age of 18
- Level of English insufficient to provide informed consent or complete the psychological questionnaires
- Refusal to participate
- Already engaged in a weekly group choir
- Started a formal course of psychological therapy in the past 1 month or scheduled to start in the next 12 weeks
- Started any new medication for anxiety or depression in the last month
- Currently having chemotherapy or radiotherapy or less than 90 days since last session
- Scheduled for surgery in the next 12 weeks or less than 90 days post surgery
- Have a current diagnosis of an additional immune condition e.g. lupus
- Currently being treated with steroids or immunosuppressive medication
- Participants who are pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Royal Marsden NHS Foundation Trustlead
- London Cancer Alliancecollaborator
- Royal College of Musiccollaborator
- Tenovus Cancer Carecollaborator
Study Sites (1)
Royal Marsden Hospital NHS Foundation Trust
London/Surrey, United Kingdom
Related Publications (1)
Fancourt D, Finn S, Warran K, Wiseman T. Group singing in bereavement: effects on mental health, self-efficacy, self-esteem and well-being. BMJ Support Palliat Care. 2022 Oct;12(e4):e607-e615. doi: 10.1136/bmjspcare-2018-001642. Epub 2019 Jun 26.
PMID: 31243022DERIVED
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Theresa Wiseman, PhD
Royal Marsden NHS Foundation Trust
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 28, 2016
First Posted
April 29, 2016
Study Start
April 1, 2016
Primary Completion
December 1, 2017
Study Completion
April 1, 2018
Last Updated
April 29, 2016
Record last verified: 2016-04
Data Sharing
- IPD Sharing
- Will not share